导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.38% | 468/1050 |
| 近一周 | -2.19% | 486/1104 |
| 近一月 | -2.82% | 324/1102 |
| 近一季 | -7.23% | 539/1092 |
| 近半年 | -4.45% | 582/1070 |
| 近一年 | 8.58% | 376/1018 |
| 近两年 | 86.85% | 241/926 |
| 近三年 | 38.57% | 332/834 |
| 成立以来 | 159.91% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.74% 430/1070 |
14.03% 468/1101 |
- - |
- - |
| 2025 | 39.70% 330/1065 |
6.80% 299/1014 |
7.04% 192/1038 |
18.35% 654/1050 |
3.25% 232/1065 |
| 2024 | 0.72% 560/1011 |
-9.36% 752/960 |
-7.00% 746/983 |
13.87% 314/991 |
4.93% 142/1011 |
| 2023 | -2.47% 148/952 |
8.97% 144/880 |
-4.37% 486/895 |
-2.63% 189/915 |
-3.88% 396/952 |
| 2022 | -15.97% 198/867 |
-15.00% 263/773 |
8.61% 321/806 |
-11.17% 314/845 |
2.46% 301/867 |
| 2021 | 29.39% 75/740 |
1.08% 105/580 |
15.49% 226/659 |
4.32% 135/704 |
6.25% 173/740 |
| 2020 | 40.13% 299/554 |
-0.46% 168/419 |
19.79% 288/466 |
12.98% 179/517 |
4.01% 454/554 |
| 2019 | 32.01% 279/410 |
30.14% 371/1146 |
-5.52% 743/1228 |
-0.69% 351/390 |
8.11% 236/410 |
| 2018 | -22.75% 110/349 |
- - |
-12.68% 630/990 |
-3.84% 406/1000 |
-6.81% 99/1080 |
| 2017 | -8.84% 191/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信量化多因子股票A VS. 东吴新产业精选股票A(580008) |